English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Syngenta completed tender offer for Devgenqrcode

Jan. 29, 2013

Favorites Print
Forward
Jan. 29, 2013
Syngenta announced that, upon closing of the mandatory reopening of its bid for Devgen, 98.32% of the total number of shares in Devgen have been tendered. Payment for the shares already tendered will take place on January 30, 2013.

As Syngenta has now acquired more than 95% of the shares in Devgen, it will proceed with a simplified squeeze-out in order to acquire by operation of law the remaining shares and warrants. The squeeze-out will take place from February 6, 2013 until February 26, 2013 (16:00 Central European Time) and will be settled on March 8, 2013. Upon settlement of the squeeze-out, all the shares will have been acquired by Syngenta and will be automatically delisted from NYSE Euronext Brussels.

The prospectus relating to the tender offer and the Devgen Board memorandum of response recommending the offer were approved by the Belgian Financial Markets and Services Authority on November 8, 2012.

0/1200

More from AgroNewsChange

Hot Topic More

Subscribe Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe AgroNews Daily Alert to send news related to your mailbox